Phototherapy for neonatal hyperbilirubinemia

Area of Science:

• Biochemistry
• Pediatrics
• Photochemistry

Background:

• Phototherapy for neonatal hyperbilirubinemia was introduced ~60 years ago.
• The mechanism of bilirubin reduction by phototherapy was initially unknown.
• Early research utilized Gunn rats to understand bilirubin photoisomerization and excretion.

Purpose of the Study:

• To review the photochemical reactions of bilirubin during phototherapy.
• To discuss the knowns and unknowns of phototherapy for neonatal hyperbilirubinemia.
• To explore potential risks associated with phototherapy, including carcinogenic effects and mortality in premature infants.

Main Methods:

• Literature review of phototherapy for neonatal hyperbilirubinemia.
• Analysis of photochemical reactions of bilirubin.
• Examination of historical data and clinical observations.

Main Results:

• Phototherapy decreases serum bilirubin by promoting the excretion of geometric configurational photoisomers.
• The primary mechanism involves the formation and excretion of bilirubin photoisomers, differing from Gunn rat models.
• Optimal light sources and evaluation methods remain undetermined.

Conclusions:

• Bilirubin photoisomerization and excretion is the main mechanism for serum bilirubin reduction.
• Further research is needed to identify the safest and most effective phototherapy protocols.
• Potential adverse effects, such as bronze baby syndrome and risks to extremely low-birthweight infants, warrant careful consideration.